Dr. Robert Garnick has joined Peregrine Pharmaceuticals as the head of regulatory affairs. Dr. Garnick was formerly the senior vice president of regulatory, quality and compliance at Genentech. During his 24-year career at that company, he was responsible for 17 new product approvals, including most of the company’s top selling monoclonal antibody therapeutics such as Rituxan, Herceptin, Avastin and Lucentis. Dr. Garnick will be responsible for overseeing Peregrine’s interactions wit...